[ Price : $8.95]
FDA awards Neuren Pharmaceuticals a rare pediatric disease designation for its drug candidate NNZ-2591 and its use in treating Phe...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection entitled Diversity Action Plans (DAPs) for Clinical Studi...[ Price : $8.95]
FDA releases the form FDA-483 with seven observations from an inspection at the Englewood, CO-based Leiters Health outsourcing fac...[ Price : $8.95]
FDA recommends that Agenus not submit its BOT/BAL colorectal cancer treatment for accelerated approval.[ Price : $8.95]
FDA classifies as official action indicated an April inspection of Zydus Lifesciences injectables manufacturing facility at Jarod,...[ Price : $8.95]
Aveo Oncology says its Phase 3 trial of Fotivda plus BMS Opdivo in some renal cell cancer patients did not meet the progression-fr...[ Price : $8.95]
FDA clears a Globus Medical 510(k) for its ExcelsiusFlex with total knee arthroplasty option.[ Price : $8.95]
FDA grants Restore Medical a breakthrough device designation for its ContraBand device and its use in treating certain heart failu...